Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Patients With Complex Congenital Heart Disease
6. května 2026 aktualizováno: Sung Eun Hyun, Seoul National University Hospital
Preliminary Efficacy of a Community-Based Remote Cardiac Rehabilitation Program on Cardiopulmonary Function and Quality of Life in Pediatric Patients With Complex Congenital Heart Disease: A Single Blind, Randomized Controlled Trial
This study aims to evaluate the preliminary efficacy of a 12-week community-based remote cardiac rehabilitation program on cardiopulmonary function and quality of life in pediatric patients (aged 8 to 18 years) with complex congenital heart disease.
Participants will be randomly assigned to either an experimental group receiving the remote cardiac rehabilitation program or a control group receiving the standard of care.
Přehled studie
Postavení
Nábor
Podmínky
Typ studie
Intervenční
Zápis (Odhadovaný)
45
Fáze
- Nelze použít
Kontakty a umístění
Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.
Studijní kontakt
- Jméno: Sungbae Jo Research Professor, Ph.D
- Telefonní číslo: 82-2-2072-4178
- E-mail: sungbaejo@snuh.org
Studijní místa
-
-
-
Seoul, Jižní Korea, 03080
- Nábor
- Seoul National University Hospital
-
Kontakt:
- Sungbae Jo Research Professor, Ph.D
- Telefonní číslo: 82-2-2072-4178
- E-mail: sungbaejo@snuh.org
-
-
Kritéria účasti
Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
Přijímá zdravé dobrovolníky
Ne
Popis
Inclusion Criteria:
- Aged 8 to 18 years.
- Diagnosed with complex congenital heart disease (e.g., single ventricle, transposition of the great arteries) and have a history of cardiac surgery.
- At least 3 months post-cardiac surgery and maintaining a stable hemodynamic status.
- Capable of utilizing remote programs (mobile apps, video platforms, etc.) in the home environment with technical support from guardians.
- Participant or guardian has agreed to participate and signed the written informed consent form.
- Confirmed to have decreased physical activity level and physical well-being through assessments (Must meet both):
- KIDSCREEN-27 Parent Proxy-report 'Physical well-being' domain T-score of 40 or below.
- Exercise Vital Sign (EVS) survey indicating moderate-to-vigorous physical activity (MVPA) time of less than 420 minutes per week.
Exclusion Criteria:
- Ongoing cardiovascular diseases such as uncontrolled arrhythmia, acute heart failure, myocarditis, or pericarditis.
- Neurological or musculoskeletal disorders that make independent exercise impossible.
- Cognitive impairment that prevents understanding or following the instructions of the remote rehabilitation program.
- Clinical levels of depression or anxiety restricting exercise participation, as determined by the attending physician (assessed via Korean Children's Depression Inventory 2: Self-Report [K-CDI-2:SR] and Revised Children's Manifest Anxiety Scale, Second Edition [RCMAS-2]).
- Inability to cooperate with study tests, such as the Cardiopulmonary Exercise Test (CPET), Electrocardiogram (ECG), and 6-Minute Walk Test (6MWT).
- Currently wearing an artificial pacemaker.
Studijní plán
Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Remote Cardiac Rehabilitation Group
Participants randomly assigned to this group will receive a 12-week remote cardiac rehabilitation program followed by a 12-week follow-up period (total 24 weeks).
|
The program consists of supervised remote exercise via ZOOM once a week (approx.
60 minutes, including warm-up, aerobic, resistance, respiratory, and cool-down exercises) and self-directed exercise 3 to 7 times a week.
Biological signals (ECG, heart rate, SpO2) are monitored using wearable devices (mobiCARE, pulse oximeter, and smartwatch).
A respiratory muscle training device (POWERbreathe) is also utilized.
Participants will maintain their usual outpatient care, medications, and standard physical activity guidelines for without the remote structured intervention.
|
|
Aktivní komparátor: Control Group
Participants randomly assigned to this group will receive the standard of care for 24 weeks.
After the 24-week evaluation, they will be offered a 1-month exercise education program opportunity.
|
Participants will maintain their usual outpatient care, medications, and standard physical activity guidelines for without the remote structured intervention.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Maximal Oxygen Consumption (VO2 max)
Časové okno: Baseline (Week 0), 12 weeks
|
Measured by Cardiopulmonary Exercise Test (CPET) using the OSAKA protocol.
It assesses the maximal amount of oxygen the body can utilize during exercise.
|
Baseline (Week 0), 12 weeks
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Pediatric Quality of Life Inventory (PedsQL) Total Score
Časové okno: Baseline (Week 0), 12 weeks, 24 weeks
|
Health-related quality of life assessed by the PedsQL questionnaire.
Total scores range from 0 to 100, where higher scores indicate a better outcome (higher health-related quality of life).
|
Baseline (Week 0), 12 weeks, 24 weeks
|
|
Cardiac Rehabilitation Program Attendance Rate
Časové okno: 12 weeks, 24 weeks
|
Calculated as the number of participated sessions divided by the total number of provided sessions (%).
|
12 weeks, 24 weeks
|
|
Drop-out Rate
Časové okno: 12 weeks, 24 weeks
|
Percentage of participants who dropped out related to the intervention
|
12 weeks, 24 weeks
|
|
Change in Physical Activity Level
Časové okno: Baseline, 12 weeks, 24 weeks
|
Measured by an accelerometer (GENEActiv) worn for 7 days and smartwatch data.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Global Physical Activity Questionnaire (GPAQ) Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
Assesses levels of physical activity in three domains (activity at work/school, travel to and from places, recreational activities) and sedentary behavior.
The Global Physical Activity Questionnaire (GPAQ) calculates physical activity volume in Metabolic Equivalent of Task (MET)-minutes per week, with a minimum value of 0 and no defined maximum limit, where higher values indicate a better outcome (greater physical activity).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Pediatric Quality of Life Inventory (PedsQL) Parent Proxy-Report Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
Assesses health-related quality of life of the pediatric patient from the perspective of the parents or guardians.
Total scores range from 0 to 100, where higher scores indicate a better outcome (higher health-related quality of life).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Pediatric Quality of Life Inventory (PedsQL) Cardiac Module Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
A disease-specific module designed to measure health-related quality of life specifically in pediatric patients with heart disease.
Total scores range from 0 to 100, where higher scores indicate a better outcome (better disease-specific quality of life).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Pediatric Quality of Life Inventory (PedsQL) Cardiac Module Parent Proxy-Report Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
A disease-specific module designed to measure health-related quality of life specifically in parent proxy-report of pediatric patients with heart disease.
Total scores range from 0 to 100, where higher scores indicate a better outcome (better disease-specific quality of life).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Resilience Scale for Youth (RS-Y) Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
Assesses the level of psychological resilience in children and adolescents.
Total scores range from 37 to 185 (based on 37 items), where higher scores indicate a better outcome (greater psychological resilience).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Child Behavior Checklist (CBCL) Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
Evaluates behavioral and emotional problems in children and adolescents, as reported by parents or guardians.
Results are reported as T-scores typically ranging from 28 to 100, where higher scores indicate a worse outcome (more severe behavioral or emotional problems).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Korean Children's Depression Inventory 2: Self-Report (K-CDI-2:SR) Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
A self-report assessment to evaluate the presence and severity of depressive symptoms in children and adolescents.
Scores range from 0 to 56, where higher scores indicate a worse outcome (more severe depressive symptoms).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Revised Children's Manifest Anxiety Scale, Second Edition (RCMAS-2) Score
Časové okno: Baseline, 12 weeks, 24 weeks
|
A self-report instrument designed to assess the level and nature of anxiety in children and adolescents.
Results are reported as scores typically ranging from 0 to 40, where higher scores indicate a worse outcome (greater severity of anxiety).
|
Baseline, 12 weeks, 24 weeks
|
|
Incidence of Adverse Events (Safety)
Časové okno: 12 weeks, 24 weeks
|
Proportion and rate of adverse events and serious adverse events occurring during exercise.
|
12 weeks, 24 weeks
|
|
Change in Oxygen Consumption (VO2)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The volume of oxygen consumed per minute during the cardiopulmonary exercise test.
Unit: L/min.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Carbon Dioxide Production (VCO2)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The volume of carbon dioxide produced per minute during the cardiopulmonary exercise test.
Unit: L/min.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Respiratory Exchange Ratio (RER)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The ratio of carbon dioxide production to oxygen consumption during the cardiopulmonary exercise test.
Unit: Ratio
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Minute Ventilation (VE)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The total volume of air inhaled and exhaled per minute during the cardiopulmonary exercise test.
Unit: L/min.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Ventilatory Equivalent for Oxygen (VE/VO2)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The ratio of minute ventilation to oxygen consumption, reflecting ventilatory efficiency.
Unit: Ratio
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Ventilatory Equivalent for Carbon Dioxide (VE/VCO2)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The ratio of minute ventilation to carbon dioxide production, reflecting ventilatory efficiency.
Unit: Ratio
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Oxygen Pulse (O2 Pulse)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The amount of oxygen consumed per heart beat during the cardiopulmonary exercise test.
Unit: mL/beat.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Peripheral Capillary Oxygen Saturation (SpO2)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The blood oxygen saturation level measured via pulse oximetry during the cardiopulmonary exercise test.
Unit: %.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Maximal Heart Rate (HRmax)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The highest heart rate achieved during the cardiopulmonary exercise test.
Unit: beats per minute (bpm).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Skeletal Muscle Mass measured by Bioelectrical Impedance Analysis (BIA)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The total weight of skeletal muscle in the body measured by bioelectrical impedance analysis.
Unit: kg.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Fat Mass measured by Bioelectrical Impedance Analysis (BIA)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The total weight of fat in the body measured by bioelectrical impedance analysis.
Unit: kg.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Percent Body Fat measured by Bioelectrical Impedance Analysis (BIA)
Časové okno: Baseline, 12 weeks, 24 weeks 13.
|
The percentage of total body weight that consists of fat, measured by bioelectrical impedance analysis.
Unit: %.
|
Baseline, 12 weeks, 24 weeks 13.
|
|
Change in Abdominal Fat Ratio measured by Bioelectrical Impedance Analysis (BIA)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The ratio of abdominal fat, evaluated by waist-to-hip circumference ratio via bioelectrical impedance analysis.
Unit: %.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Extracellular Water Ratio measured by Bioelectrical Impedance Analysis (BIA)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The ratio of extracellular water to total body water, measured by bioelectrical impedance analysis.
Unit: %.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Radial Artery Augmentation Index (AIx)
Časové okno: Baseline, 12 weeks, 24 weeks
|
A measure of arterial stiffness derived from the radial artery pulse wave, standardized to a heart rate of 75 bpm (AIx@75).
Unit: %.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Carotid-femoral Pulse Wave Velocity (c-f PWV)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The speed of the arterial pulse propagating from the carotid to the femoral artery, reflecting arterial stiffness.
Unit: m/s.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Flow-Mediated Dilation (FMD)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The percentage increase in brachial artery diameter following a period of ischemia, assessing endothelial function.
Unit: %.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in 6-Minute Walk Test (6MWT) Distance
Časové okno: Baseline, 12 weeks, 24 weeks
|
The total distance a participant can walk on a flat, hard surface in exactly 6 minutes.
Unit: meters (m).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Lower Limb Strength measured by isokinetic dynamometer (Biodex)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The maximum isometric knee extension peak torque measured by an isokinetic dynamometer.
Unit: Newton meters (N.m).
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Lower Limb Muscular Endurance measured by 1-minute squats
Časové okno: Baseline, 12 weeks, 24 weeks
|
The total number of chair stand squats completed within exactly one minute.
Unit: repetitions.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Upper Limb Strength (Grip Strength)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The maximum isometric handgrip strength measured using a hand dynamometer.
Unit: kg.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Flexibility measured by sit and reach test
Časové okno: Baseline, 12 weeks, 24 weeks
|
The maximum distance reached forward while sitting with legs extended, assessing lower back and hamstring flexibility.
Unit: cm.
|
Baseline, 12 weeks, 24 weeks
|
|
Change in Maximal Inspiratory Pressure (MIP)
Časové okno: Baseline, 12 weeks, 24 weeks
|
The maximum pressure generated during inspiration against an occluded airway, assessing respiratory muscle strength.
Unit: mmH2O.
|
Baseline, 12 weeks, 24 weeks
|
Spolupracovníci a vyšetřovatelé
Zde najdete lidi a organizace zapojené do této studie.
Spolupracovníci
Termíny studijních záznamů
Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.
Hlavní termíny studia
Začátek studia (Odhadovaný)
1. května 2026
Primární dokončení (Odhadovaný)
31. října 2029
Dokončení studie (Odhadovaný)
31. prosince 2029
Termíny zápisu do studia
První předloženo
23. dubna 2026
První předloženo, které splnilo kritéria kontroly kvality
6. května 2026
První zveřejněno (Aktuální)
7. května 2026
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
7. května 2026
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
6. května 2026
Naposledy ověřeno
1. dubna 2026
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2511-022-1690
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
NEROZHODNÝ
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Ne
Studuje produkt zařízení regulovaný americkým úřadem FDA
Ne
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .